Torti's Next Hundred Days: Active, Not Just Acting FDA Commissoner
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Chief Scientist will continue to push for outside academic collaborations during his "short time" atop the agency; fall letter on follow-on biologics could draw closer reading.